H.R. 4116 · 115th Congress
Transparent Drug Pricing Act of 2017
- Stage
- In committee
- Sponsor
- Lloyd Doggett
- Introduced
- 2017-10-25
- Latest action
- 2017-10-27 · Referred to the Subcommittee on Health.
Summary
Transparent Drug Pricing Act of 2017
This bill requires drug manufacturers to report specified financial and sales information, including drug pricing, tax credit, and patent information; violations are subject to civil penalties.